Literature DB >> 20848681

Infliximab, azathioprine, or combination therapy for Crohn's disease.

Cesare Ruffolo, Marco Scarpa, Nicolò Bassi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848681     DOI: 10.1056/NEJMc1005805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  The Presence of Postoperative Infectious Complications is Associated with the Risk of Early Postoperative Clinical Recurrence of Crohn's Disease.

Authors:  Zhen Guo; Lei Cao; Feilong Guo; Jianfeng Gong; Yi Li; Lili Gu; Weiming Zhu; Jieshou Li
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

2.  Association of polymorphisms in C1orf106, IL1RN, and IL10 with post-induction infliximab trough level in Crohn's disease patients.

Authors:  Jian Tang; Cai-Bin Zhang; Kun-Sheng Lyu; Zhong-Ming Jin; Shao-Xing Guan; Na You; Min Huang; Xue-Ding Wang; Xiang Gao
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-10-29

3.  Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.

Authors:  Yu Yu; Hong Zhao; Youyou Luo; Jingan Lou; Jie Chen; Youhong Fang
Journal:  Dig Dis Sci       Date:  2021-04-05       Impact factor: 3.199

Review 4.  In vitro models of intestinal epithelium: Toward bioengineered systems.

Authors:  Justine Creff; Laurent Malaquin; Arnaud Besson
Journal:  J Tissue Eng       Date:  2021-02-01       Impact factor: 7.813

Review 5.  Effects of immunosuppressants on immune response to vaccine in inflammatory bowel disease.

Authors:  Yuan Cao; Di Zhao; An-Tao Xu; Jun Shen; Zhi-Hua Ran
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

6.  Short-Term Outcome of Infliximab Therapy in Pediatric Crohn's Disease: A Single-Center Experience.

Authors:  Dai Jung; Sunghee Lee; Insook Jeong; Seak Hee Oh; Kyung Mo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-12-22

7.  Influence of previous corticosteroid treatment on the efficacy and safety of infliximab therapy in Crohn disease.

Authors:  Ailing Liu; Yue Li; Hong Yang; Hong Lv; Jiaming Qian
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 8.  One Size Does Not Fit All: The Case for Translational Medicine.

Authors:  Yehuda Chowers
Journal:  Rambam Maimonides Med J       Date:  2019-04-18

9.  Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis.

Authors:  Xiaobing Wang; Ge Wang; Jian Shang; Huaqin Pan; Xin A Zhang; Feng Zhou
Journal:  J Int Med Res       Date:  2019-07-31       Impact factor: 1.671

Review 10.  Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.

Authors:  Jun-Hwan Yoo; Mark Donowitz
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.